Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 14
Original Research
Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,648 | Dovepress* | 8,047+ | 1,325 | 9,372 | |
| PubMed Central* | 601 | 168 | 769 | ||
| Totals | 8,648 | 1,493 | 10,141 | ||
| *Since 4 May 2018 | |||||
View citations on PubMed Central and Google Scholar